Toshio Kawata
Tokyo, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Ceralasertib, an ATR kinase inhibitor, as monotherapy in Japanese patients with advanced solid malignancies: Results from a phase 1 study.
Journal: Investigational new drugs
Published: August 05, 2025
Safety and efficacy of acalabrutinib and obinutuzumab in treatment-naive chronic lymphocytic leukemia: a Japanese phase 1 study.
Journal: Leukemia & lymphoma
Published: July 02, 2024
Safety, tolerability, pharmacokinetics, and antitumor activity of adavosertib in Japanese patients with advanced solid tumors: A phase I, open-label study.
Journal: Cancer treatment and research communications
Published: November 30, 2023
Prediction of the Contribution Ratio of a Target Metabolic Enzyme to Clearance from Chemical Structure Information.
Journal: Molecular pharmaceutics
Published: December 20, 2022
Gefitinib exposure and occurrence of interstitial lung disease in Japanese patients with non-small-cell lung cancer.
Journal: Cancer chemotherapy and pharmacology
Published: November 04, 2018
Safety and tolerability of the olaparib tablet formulation in Japanese patients with advanced solid tumours.
Journal: Cancer chemotherapy and pharmacology
Published: June 23, 2016
Safety and tolerability of AZD5363 in Japanese patients with advanced solid tumors.
Journal: Cancer chemotherapy and pharmacology
Published: January 15, 2016
Showing 1-8 of 8
Last Updated: 09/26/2026